華大基因整合基因組、蛋白質組、空間組

🔑 增強重點摘要

• •The acquisition of Chongqing Xinyichan specifically bolsters BGI's capabilities in high-throughput mass spectrometry, a critical component for bridging the gap between genomic data and functional proteomic expression.
• •This integration leverages BGI's proprietary DNBSEQ sequencing technology alongside spatial transcriptomics platforms (such as Stereo-seq) to create a unified data pipeline for single-cell multi-omics analysis.
• •The strategic move is designed to accelerate drug discovery and precision medicine workflows by reducing the time-to-insight for complex biological samples that require simultaneous DNA, RNA, and protein profiling.

🛠️ 技術深入

• •Integration of DNBSEQ (DNA Nanoball Sequencing) with mass spectrometry-based proteomics allows for cross-validation of genomic variants with protein expression levels.
• •Utilization of Stereo-seq (Spatial Enhanced Resolution Omics-sequencing) provides sub-cellular resolution (nanometer scale) for spatial mapping of transcripts.
• •Implementation of a unified bioinformatics pipeline that synchronizes multi-dimensional data layers, enabling the correlation of spatial coordinates with proteomic abundance and genomic mutations.

🔮 前景展望AI analysis grounded in cited sources

⏳ 時間線